Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-004907)

Filing Details

Accession Number:: 0000899243-20-004907
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-18 16:59:16
Reporting Period:: 2020-02-14

Accepted Time:: 2020-02-18 16:59:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1346302	Xeris Pharmaceuticals Inc	XERS	Pharmaceutical Preparations (2834)	203352427

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1743774	Erland Kenneth Johnson	C/O Xeris Pharmaceuticals, Inc. 180 N. Lasalle Street, Suite 1600 Chicago IL 60601	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-02-14	2,410	$4.15	6,115	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents shares purchased in an underwritten public offering of the Issuer at the public offering price of $4.15 per share.